Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D7HU
|
||||
| Former ID |
DNC014006
|
||||
| Drug Name |
7-Phenyl-1-(2H-tetrazol-5-yl)-heptan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529594] | ||
| Formula |
C14H18N4O
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NNN=N2
|
||||
| InChI |
1S/C14H18N4O/c19-13(14-15-17-18-16-14)11-7-2-1-4-8-12-9-5-3-6-10-12/h3,5-6,9-10H,1-2,4,7-8,11H2,(H,15,16,17,18)
|
||||
| InChIKey |
JVOYAZCLPXVADL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529594] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.